Renoprotective effects of novel interleukin-1 receptor-associated kinase 4 inhibitor AS2444697 through anti-inflammatory action in 5/6 nephrectomized rats

IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine

(2012) Claudio Pozzi et al.   JOURNAL OF NEPHROLOGY

High-calorie diet with moderate protein restriction prevents cachexia and ameliorates oxidative stress, inflammation and proteinuria in experimental chronic kidney disease

(2010) Hyun Ju Kim et al.   Clinical and Experimental Nephrology

Pirfenidone: an anti-fibrotic therapy for progressive kidney disease

(2010) Monique E Cho et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Common pathophysiological mechanisms of chronic kidney disease: Therapeutic perspectives

(2010) José M. López-Novoa et al.   PHARMACOLOGY & THERAPEUTICS

Persistent Inflammation as a Catalyst for Other Risk Factors in Chronic Kidney Disease: A Hypothesis Proposal

(2009) J. J. Carrero et al.   Clinical Journal of the American Society of Nephrology

IRAK-4 Inhibitors for Inflammation

(2009) Zhulun Wang et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Lymphocytes are dispensable for glomerulonephritis but required for renal interstitial fibrosis in matrix defect-induced Alport renal disease

(2008) Valerie S LeBleu et al.   LABORATORY INVESTIGATION

Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease

(2008) Douglas M. Silverstein   PEDIATRIC NEPHROLOGY